
Prism AI Therapeutics provides a global SaaS platform for the development and commercialization of multi-omic diagnostic (Dx) and companion diagnostic (CDx) assets. Our proprietary quantum mechanics-based AI/ML is uniquely able to transform real-world noisy and high-dimensional multi-omic data into accurate, precise, actionable and mechanistically interpretable biomarkers from as few as 18 patients. Our predictors—of drug efficacy, toxicity, and targets—consistently validate and outperform all others, improving drug development success rates and expanding the patient addressable…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.